|
Adherence with medication regimens is reviewed by the nurse practitioner or physician, and the list of
prescribed medications is compared with what the patient is actually taking according the pharmacist. Blood
pressure, A1C and cholesterol measurements are taken as a baseline before the consulting session, and compared with
readings three months after this session. Using such objective outcomes to measure the success of medication
management therapy is pivotal in setting a systems change project. Objective outcomes as markers, such as LDL, A1C,
and blood pressure to measure results with outpatient drug therapy is especially important when addressing
polypharmacy management in the elderly. 11
Three months after the counseling session, objective lab values were obtained to determine any
improvement in chronic disease management that could be associated with the counseling. After the counseling
session, a detailed note was provided by the PharmD to the primary care provider with an overview of the counseling
suggestions, such as list of the medications changes or labs that were needed. This note was then filed in the
patient's chart. When following up with the primary care provider, the patient and provider review the suggestions
provided by the PharmD.
Barriers
In the beginning stages of implementation, it was noted that the reports from the SafeMed pharmacists
included recommendations for the primary care provider that were embedded in the pharmaceutical consult note, and
were being overlooked. These recommendations were being overlooked due to the layout of the note from the
pharmacist. Because of this, a request was made to SafeMed to separate the recommendations into a separate section
on the form. A plan section was then integrated into the form of the pharmaceutical consult note to advise the
patients' nurse of recommended changes or follow up in drug therapy.
During the implementation stage, a decision was made to train the nurses in the importance of placing
these pharmaceutical consult notes on the patients' charts and bringing these notes to the provider, advising the
nurse practitioner or physician of the new recommendation section on the form. Nurses also notify the patients of
the changes that the provider would like to make based on the recommendations provided by the pharmacist. Only
after the form has been reviewed by the nursing staff and signed by the nurse practitioner or physician is the form
filed away.
Analyses
Outcomes are analyzed through a random chart review of patients referred to this counseling. Chart
reviews have been shown to be an effective means to review outcomes of quality improvement projects in outpatient
settings. 12
Medication review with patients showed improved results with drug adherence and chronic disease markers
in Australia. 13 Results were analyzed from charts through comparing A1C, LDL, and blood pressure values with
precounseling values.
The outcomes of this counseling are reviewed with the nurse practitioner or physician three months after
pharmacist telephone consultation.
Survey forms discussed above are filled out by patients at the time of the follow up with the healthcare
provider. Survey forms are kept anonymous and are reviewed by the office manager. One hundred percent of the
patients filled out the survey forms, and these results are discussed.
Results
Patient satisfaction was evaluated from the survey forms given by the pharmD and satisfaction rate
averaged 95%. Patients' only complaint was the delay in the time of counseling from the time of referral. This
apparently was due to language barriers (some patients only speak some Spanish and were unable to find
interpreters), and also due to disconnected phone numbers. Patients clearly stated in their survey forms that they
were able to understand their medication regimens more clearly, and questions were answered appropriately. Although
none of the patients referred to pharmaceutical counseling understood their medication purpose and regimens, ninety
percent of the patients confirmed that they understood the indications of their medications after the
pharmaceutical counseling.
|